alk positive lung cancer in 2023 and beyond: thinking outside the box with dr. alice shaw
Published 1 year ago • 5K plays • Length 42:31Download video MP4
Download video MP3
Similar videos
-
1:00:52
drshaw
-
57:10
alk positive summit 2022: thinking out of the box- non-standard therapies for alk positive patients
-
4:23
alecensa: targeted therapy for alk-positive lung cancer
-
6:02
shaw patterns of resistance in alk positive nsclc
-
1:38
dr. alice shaw describes ldk378 in alk-positive non-small cell lung cancer
-
1:09:29
alktalk1:10:20alice shaw
-
1:58
dr. shaw on crizotinib in alk-positive lung cancer
-
1:52
dr. shaw on crizotinib versus chemotherapy in alk-positive nsclc
-
2:32
dr. shaw discusses ldk378 and alectinib (af802) for alk-positive nsclc
-
1:42
dr. alice shaw compares crizotinib and chemotherapy in nsclc
-
1:51
dr. shaw on ldk378 in alk crizotinib-resistant nsclc patients
-
1:17
dr. christina baik on alectinib versus crizotinib in alk-positive lung cancer
-
8:25
alk-positive lung cancer
-
8:51
alk-positive nsclc
-
55:39
alk positive summit 2022: new therapies to treat alk positive cancers in pre-clinical developments
-
1:25
updates and unmet needs in alk-mutated lung cancer
-
33:30
ilcn molecular challenges forum: alk pioneers and progress
-
2:34
cns metastasis in alk positive lung cancer